Charitable Trust Events
Charitable Trust 2025 Annual General Meeting – October 4, 2025
The Charitable Trust Annual General Meeting will be held on Saturday, October 4, 2025 at 1:00 PM EST via zoom. It will be an opportunity for all members to hear from Lauren Stoyles, the recipient of the CFUW Linda Souter Humanities Award for 2025-26. Laura is pursuing a Master’s Degree in Public History at Carleton University where her research centres on women’s labour in museums in Canada.
Registrants are invited to make a donation to support the work of the CT here.
Read the 2024-2025 CT Annual Report here: CFUW CT Annual Report 2024-2025.
Charitable Trust 2024 Annual General Meeting – October 19, 2024
|
|
Charitable Trust Annual General Meeting – October 22, 2022
Our speaker on October 22 was Casey Oliver.
B.Sc. Science and Psychology, 2014, University of Waterloo
M.A. Counselling Psychology, 2018, University of Western Ontario
M.A. Clinical Psychology, 2021, Lakehead University
Ph.D. Clinical Psychology, 2021-2025, Lakehead University
Casey’s dissertation focuses on sexual violence that is perpetrated through technology against women. She seeks to better understand whether this type of gender-based violence effects both the mental well-being of women and their use of technology.
This could have grave implications for their academic and career participation, especially with the increasingly virtual nature of these settings due to the COVID-19 pandemic. In-turn, this research could inform prevention and response strategies, including platform and government policies
Charitable Trust AGM Speakers Panel – October 16, 2021
Presentation Abstracts:
Dr. Chubbs will talk about her path to pursuing a career in psychiatry, the structure of her residency program, current research, and future career plans.Caitilin will give an overview of her topic on psychosocial care and her research plans. She will also share insights from her preliminary fieldwork carried out virtually this summer with humanitarian organizations delivering psychosocial care in Canada, Denmark, Liberia, and Cyprus.
Dr. Brittany Chubbs
Recipient of the inaugural CFUW Aboriginal Women’s Award (AWA) 2016/17 to help fund her M.D. program at Memorial University. 
- M.D. (2019) Memorial University
- Master of Health Ethics (2017) Memorial University
- B.Sc. Biological Sciences (2015) University of Alberta
Dr. Chubbs is completing a residency in Psychiatry at the University of Alberta. She is part of a research team that is conducting a study on the addictive potential\risks associated with ketamine when used as a treatment for Major Depressive Disorder (MDD).
Caitilin McMillan
CFUW 100th Anniversary Legacy Fellowship 2021 inaugural winner. Caitilin is a doctoral candidate at the University of North Carolina at Chapel Hill.
- M.Sc. Migration Studies (2011) University of Oxford
- B.A. Global Development Studies Honours Program (2010) Queen’s University
Caitilin works with women survivors of war and torture to improve mental health and psychosocial care practices in the aftermath of violence.Psychosocial approaches still remain a relative ‘black box’ within the humanitarian sector, but broadly offer a way of thinking about care that captures the inseparable relationship between an individual’s psychological wellbeing and their embeddedness in the wider social environment.
Charitable Trust Virtual Brunch Fundraising Event – June 26, 2021
Speaker: Priye Iworima CFUW 1989 École Polytechnique Commemorative (Ph.D.) Awardee 2019 for research in Biomedical Engineering at UBC
Title: Cell replacement therapy as a potential treatment for diabetes using differentiated stem cells
Presentation Abstract: Diabetes is characterized by chronic high blood sugar due to a deficiency of insulin from the pancreatic islets. Islet transplantation reverses high blood sugar; however, its widespread use as a form of insulin replacement therapy is limited by the scarcity of cadaveric donor islets. We are exploring stem cells as an unlimited source of insulin producing cells to treat diabetes. Using a stepwise protocol, we can convert the stem cells into insulin producing pancreatic islets. We are now optimizing this cell culture protocol while also investigating procedures that will permit large scale manufacturing of stem cell-derived islet cells. Ultimately, we hope that these cells can be used to effectively treat diabetes.
